Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Essential Arterial Hypertension
NCT05257291Phase 2Unknown
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Feb 2018
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in essential hypertension, sponsored by ASST Spedali Civili di Brescia. Primary endpoints: Systolic and diastolic blood pressure and Heart rate. Status: unknown.
02
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT05257291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05257291.